On the HCPLive Major Depressive Disorder condition center page, resources on the topics of medical news and expert insight into depression can be found. Content includes articles, interviews, videos, podcasts, and breaking news on MDD research, treatment, and drug development.
October 23rd 2024
Alto Neuroscience's ALTO-100 failed to beat placebo in a phase 2b trial for depression, leading to a 60% stock drop.
October 23rd 2024
Study Shows Growing Mental Health Crisis in England
July 12th 2023England saw a significant increase in severe psychological distress among adults over the past 3 years, highlighting the urgent need to address the growing mental health crisis and allocate sufficient resources to mental health services.
Patients With Mental Illness Utilize Social Media for Health Reasons
Patients with anxiety or depression who engaged in health-related social media usage were significantly more likely to report to report intentions to quit smoking, endorse past 12-month attempts at smoking cessation, and were more likely to meet national recommendation for weekly strength training.
Reducing the Risk of Alcohol Use During Adolescents Drops Risk of Depression in Adulthood
After making adjustments, the results show a positive association between alcohol dependence at 18 years and depression at age 24 years. However, there was no association between the rate of change and depression.
More Research Needed Focusing on Circadian Preferences and Mental Health of Student-Athletes
A preference for eveningness was significantly associated with worse overall sleep difficulties, longer sleep latency, reduced sleep satisfaction, more prolonged sleep inertia, more daytime naps, and more severe depressive symptomatology.
Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease
June 4th 2023A pair of studies presented at EULAR 2023 offer perspective on the potential for postpartum depression as well as symptoms of depression and anxiety during pregnancy among women with rheumatic disease.
Substance Use Disorder Rates Higher in Patients With Comorbid SLE, Major Depressive Disorder
Patients with comorbid major depressive disorder were more likely to have a diagnoses of tobacco, alcohol, opioid, cannabis, stimulants, hallucinogens, sedatives-hypnotics, or anxiolytic use disorders compared to patients with only systemic lupus erythematous.